119 related articles for article (PubMed ID: 38126217)
1. The evaluation of salivary leucine-rich alpha-2 glycoprotein (LRG) and C-reactive protein (CRP) in humans with periodontal health or periodontal disease.
Özer E; Yilmaz HE; Narin F; Sağlam M
J Periodontal Res; 2024 Apr; 59(2):387-394. PubMed ID: 38126217
[TBL] [Abstract][Full Text] [Related]
2. Leucine-Rich Alpha-2 Glycoprotein Is a Reliable Serum Biomarker for Evaluating Clinical and Endoscopic Disease Activity in Inflammatory Bowel Disease.
Shimoyama T; Yamamoto T; Yoshiyama S; Nishikawa R; Umegae S
Inflamm Bowel Dis; 2023 Sep; 29(9):1399-1408. PubMed ID: 36334015
[TBL] [Abstract][Full Text] [Related]
3. Salivary levels of azurocidin and soluble azurophilic granules in periodontal disease.
Jasim FS; Al-Ghurabi BH; Abdulameer LA
J Med Life; 2024 Feb; 17(2):205-209. PubMed ID: 38813360
[TBL] [Abstract][Full Text] [Related]
4. Leucine-Rich Alpha-2 Glycoprotein in Monitoring Disease Activity and Intestinal Stenosis in Inflammatory Bowel Disease.
Yoshida T; Shimodaira Y; Fukuda S; Watanabe N; Koizumi S; Matsuhashi T; Onochi K; Iijima K
Tohoku J Exp Med; 2022 Jul; 257(4):301-308. PubMed ID: 35598974
[TBL] [Abstract][Full Text] [Related]
5. Salivary fetuin-A, S100A12, and high-sensitivity C-reactive protein levels in periodontal diseases.
Ersin Kalkan R; Öngöz Dede F; Gökmenoğlu C; Kara C
Oral Dis; 2018 Nov; 24(8):1554-1561. PubMed ID: 29949223
[TBL] [Abstract][Full Text] [Related]
6. Early change in serum leucine-rich α-2-glycoprotein predicts clinical and endoscopic response in ulcerative colitis.
Karashima R; Sagami S; Yamana Y; Maeda M; Hojo A; Miyatani Y; Nakano M; Matsuda T; Hibi T; Kobayashi T
Intest Res; 2024 Jun; ():. PubMed ID: 38835140
[TBL] [Abstract][Full Text] [Related]
7. Significance of Serum Leucine-rich Alpha-2 Glycoprotein as a Diagnostic Marker in Pediatric Inflammatory Bowel Disease.
Yoshimura S; Okata Y; Ooi M; Horinouchi T; Iwabuchi S; Kameoka Y; Watanabe A; Kondo A; Uemura K; Tomioka Y; Samejima Y; Nakai Y; Nozu K; Kodama Y; Bitoh Y
Kobe J Med Sci; 2024 Jan; 69(4):E122-E128. PubMed ID: 38379274
[TBL] [Abstract][Full Text] [Related]
8. Leucine-rich α2 -glycoprotein as a potential biomarker for joint inflammation during anti-interleukin-6 biologic therapy in rheumatoid arthritis.
Fujimoto M; Serada S; Suzuki K; Nishikawa A; Ogata A; Nanki T; Hattori K; Kohsaka H; Miyasaka N; Takeuchi T; Naka T
Arthritis Rheumatol; 2015 May; 67(8):2056-60. PubMed ID: 25917892
[TBL] [Abstract][Full Text] [Related]
9. Leucine-rich alpha-2 glycoprotein as a potential biomarker for large vessel vasculitides.
Umezawa N; Mizoguchi F; Maejima Y; Kimura N; Hasegawa H; Hosoya T; Fujimoto M; Kohsaka H; Naka T; Yasuda S
Front Med (Lausanne); 2023; 10():1153883. PubMed ID: 37215715
[TBL] [Abstract][Full Text] [Related]
10. Salivary histone deacetylase in periodontal disease: A cross-sectional pilot study.
Liaw A; Liu C; Bartold M; Ivanovski S; Han P
J Periodontal Res; 2023 Apr; 58(2):433-443. PubMed ID: 36717759
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of Serum Leucine-rich Alpha 2 Glycoprotein in Crohn's Disease: Is There Any Difference between Small Intestine and Colonic Lesions?
Matsumoto S; Mashima H
Crohns Colitis 360; 2023 Jul; 5(3):otad028. PubMed ID: 37288327
[TBL] [Abstract][Full Text] [Related]
12. Serum leucine-rich alpha-2 glycoprotein as a predictive factor of endoscopic remission in Crohn's disease.
Abe I; Shiga H; Chiba H; Miyazawa T; Oomori S; Shimoyama Y; Moroi R; Kuroha M; Kakuta Y; Kinouchi Y; Masamune A
J Gastroenterol Hepatol; 2022 Sep; 37(9):1741-1748. PubMed ID: 35641439
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers for Monitoring of Changes in Disease Activity in Ulcerative Colitis.
Tatsumi Y; Kakimoto K; Hara A; Mizuta N; Numa K; Kinoshita N; Nakazawa K; Koshiba R; Hirata Y; Ota K; Miyazaki T; Nakamura S; Sakagami K; Arimitsu S; Ito H; Nishikawa H
J Clin Med; 2023 Nov; 12(22):. PubMed ID: 38002777
[TBL] [Abstract][Full Text] [Related]
14. Serum leucine-rich α2 glycoprotein as a potential biomarker for systemic inflammation in Parkinson's disease.
Ohmichi T; Kasai T; Shinomoto M; Kitani-Morii F; Fujino Y; Menjo K; Mizuno T
PLoS One; 2023; 18(2):e0282153. PubMed ID: 36812242
[TBL] [Abstract][Full Text] [Related]
15. Appropriate leucine-rich α-2 glycoprotein cut-off value for Japanese patients with ulcerative colitis.
Yamazato M; Yanai S; Oizumi T; Eizuka M; Yamada S; Toya Y; Uesugi N; Sugai T; Matsumoto T
World J Clin Cases; 2023 Nov; 11(32):7753-7760. PubMed ID: 38073694
[TBL] [Abstract][Full Text] [Related]
16. Novel Utility of Leucine-Rich Alpha-2-Glycoprotein as a Biomarker in Ulcerative Colitis: A Predictor of Endoscopic Remission Independent of Symptoms.
Hayashi T; Kitamura K; Usami M; Miyazawa M; Nishitani M; Dejima A; Yamamoto M; Kawase S; Funaki M; Orita N; Nakagawa H; Morita K; Iida N; Seki A; Nio K; Kido H; Takayama H; Takeuchi Y; Yamada S; Takatori H; Shimada M; Saito H; Yamamoto D; Toyama T; Yamashita T
Inflamm Intest Dis; 2023 Dec; 8(4):133-142. PubMed ID: 38115911
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of galectin-3, peptidylarginine deiminase-4, and tumor necrosis factor-α levels in gingival crevicular fluid for periodontal health, gingivitis, and Stage III Grade C periodontitis: A pilot study.
Akkaya HÜ; Yılmaz HE; Narin F; Sağlam M
J Periodontol; 2022 Jan; 93(1):80-88. PubMed ID: 33913157
[TBL] [Abstract][Full Text] [Related]
18. Salivary bactericidal/permeability-increasing protein: A novel inflammatory marker associated with periodontitis.
Demirci MB; Daltaban Ö; Üstün K
Clin Oral Investig; 2023 Jun; 27(6):3159-3167. PubMed ID: 36805805
[TBL] [Abstract][Full Text] [Related]
19. ELISA for human serum leucine-rich alpha-2-glycoprotein-1 employing cytochrome c as the capturing ligand.
Weivoda S; Andersen JD; Skogen A; Schlievert PM; Fontana D; Schacker T; Tuite P; Dubinsky JM; Jemmerson R
J Immunol Methods; 2008 Jul; 336(1):22-9. PubMed ID: 18436231
[TBL] [Abstract][Full Text] [Related]
20. C - reactive protein levels in patients with periodontal disease and normal subjects.
Shojaee M; Fereydooni Golpasha M; Maliji G; Bijani A; Aghajanpour Mir SM; Mousavi Kani SN
Int J Mol Cell Med; 2013; 2(3):151-5. PubMed ID: 24551806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
